Lupin Sells US License Of Drug Technology To Salix Pharm – Wall Street Journal

Lupin Sells US License Of Drug Technology To Salix Pharm
Wall Street Journal
The Indian drug maker and Salix will collaborate in the development and marketing of a product incorporating rifaximin, Lupin said in a statement.
Salix in multimillion-dollar licensing deal with LupinBizjournals.com
Salix pays $5M to Indian firm in deal to develop new version of Local Tech Wire
Lupin Licenses US Rights for Proprietary Bioadhesive Technology PR Newswire (press release)
CNBC -Forbes -StreetInsider.com (subscription)
all 31 news articles »

read more about Lupin Sells US License Of Drug Technology To Salix Pharm – Wall Street Journal

Buy Cheap viagra online. Original indian pharmacy online store


Viagra 50mg Price Per Pill Order
Viagra 100mg Price Per Pill Order


indian viagra

Related posts:

  1. Lupin Says Central India Plant Cleared FDA Inspection – Wall Street Journal
  2. Glenmark Agrees To Give Drug License To Sanofi-Aventis – Wall Street Journal
  3. AstraZeneca Signs Drug Pact With Torrent – Wall Street Journal



Comments are closed.